Niedmann P D, Luthe H, Wieland H, Schaper G, Seidel D
Klin Wochenschr. 1983 Feb 1;61(3):133-8. doi: 10.1007/BF01486367.
The widespread use of different methods for the determination of HDL-cholesterol (in Europe: sodium phosphotungstic acid/MgCl2) in connection with enzymatic procedures (in the USA: heparin/MnCl2 followed by the Liebermann-Burchard method) but common reference values makes it necessary to evaluate not only accuracy, specificity, and precision of the precipitation step but also of the subsequent cholesterol determination. A high ratio of serum vs. concentrated precipitation reagent (10:1 V/V) leads to the formation of variable amounts of delta-3.5-cholestadiene. This substance is not recognized by cholesterol oxidase but leads to an 1.6 times overestimation by the Liebermann-Burchard method. Therefore, errors in HDL-cholesterol determination should be considered and differences up to 30% may occur between HDL-cholesterol values determined by the different techniques (heparin/MnCl2 - Liebermann-Burchard and NaPW/MgCl2-CHOD-PAP).
在欧洲,使用不同方法(磷酸钨酸钠/MgCl2)结合酶法程序测定高密度脂蛋白胆固醇;在美国,则是采用肝素/MnCl2然后用利伯曼-布赫ard方法。尽管参考值相同,但由于方法不同,不仅需要评估沉淀步骤的准确性、特异性和精密度,还需评估后续胆固醇测定的相关指标。血清与浓缩沉淀试剂的比例过高(10:1 V/V)会导致生成不同量的δ-3,5-胆甾二烯。这种物质不能被胆固醇氧化酶识别,但会使利伯曼-布赫ard方法的测定结果高估1.6倍。因此,应考虑高密度脂蛋白胆固醇测定中的误差,不同技术(肝素/MnCl2 - 利伯曼-布赫ard法和NaPW/MgCl2-CHOD-PAP法)测定的高密度脂蛋白胆固醇值之间可能会出现高达30%的差异。